BCAS1 Polyclonal Antibody, FITC Conjugated, Rabbit

Artikelnummer: BSS-BS-11462R-FITC
Artikelname: BCAS1 Polyclonal Antibody, FITC Conjugated, Rabbit
Artikelnummer: BSS-BS-11462R-FITC
Hersteller Artikelnummer: bs-11462R-FITC
Alternativnummer: BSS-BS-11462R-FITC-100
Hersteller: Bioss
Wirt: Rabbit
Kategorie: Antikörper
Applikation: IF, WB
Konjugation: FITC
Alternative Synonym: AIBC 1, AIBC1, Amplied and overexpressed in breast cancer, BCAS 1, BCAS1, BCAS1_HUMAN, Breast carcinoma amplied sequence 1, Breast carcinoma-amplied sequence 1, Novel amplied in breast cancer 1.
NaBC1 is a protein found amplified in most breast carcinoma forms. It is expressed primarily as a cytoplasmic, detergent-stable homodimer that has a tendency to interact with DYNLL1 (PIN) and DYNLL2. Breast tumor lines that exhibit 20q13.2 gene amplification express much higher levels of the protein as compared to the levels found in other breast cancer lines that do not overexpress the NaBC1 mRNA. However, this upregulation does not affect growth rate or anchoring abilities of a cell, indicating the oncogenic properties of NaBC1 differ from that of other oncogenes.
Klonalität: Polyclonal
Konzentration: 1ug/ul
Puffer: Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Quelle: KLH conjugated synthetic peptide derived from human BCAS1
Target-Kategorie: BCAS1
Application Verdünnung: WB(1:300-5000), IF(IHC-P)(1:50-200), IF(IHC-F)(1:50-200), IF(ICC)(1:50-200)